TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy.
about
Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer.Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapyTP53 mutations are associated with higher rates of pathologic complete response to anthracycline/cyclophosphamide-based neoadjuvant chemotherapy in operable primary breast cancer.High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function.Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance.
P2860
TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
TP53 status predicts long-term ...... er after primary chemotherapy.
@ast
TP53 status predicts long-term ...... er after primary chemotherapy.
@en
TP53 status predicts long-term ...... er after primary chemotherapy.
@nl
type
label
TP53 status predicts long-term ...... er after primary chemotherapy.
@ast
TP53 status predicts long-term ...... er after primary chemotherapy.
@en
TP53 status predicts long-term ...... er after primary chemotherapy.
@nl
prefLabel
TP53 status predicts long-term ...... er after primary chemotherapy.
@ast
TP53 status predicts long-term ...... er after primary chemotherapy.
@en
TP53 status predicts long-term ...... er after primary chemotherapy.
@nl
P2860
P50
P1433
P1476
TP53 status predicts long-term ...... er after primary chemotherapy.
@en
P2093
Hans P Eikesdal
P2860
P304
P356
10.3109/0284186X.2014.922215
P577
2014-06-09T00:00:00Z